SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 655, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-07-28
DOI
10.1126/scitranslmed.abn3715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
- (2022) Rana Abdelnabi et al. ANTIVIRAL RESEARCH
- Three-dose vaccination elicits neutralising antibodies against omicron
- (2022) Mary Wu et al. LANCET
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
- (2022) Peter J. Halfmann et al. NATURE
- Towards SARS-CoV-2 serotypes?
- (2022) Etienne Simon-Loriere et al. NATURE REVIEWS MICROBIOLOGY
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
- (2022) Anna L. McNaughton et al. JCI Insight
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
- (2021) Meghan E. Garrett et al. CELL
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
- (2021) Carl Graham et al. IMMUNITY
- Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
- (2021) William R. Morgenlander et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Structural basis for broad coronavirus neutralization
- (2021) Maximilian M. Sauer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
- (2021) Denicar Lina Nascimento Fabris Maeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
- (2021) William N. Voss et al. SCIENCE
- Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
- (2021) Ge Song et al. Nature Communications
- A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
- (2021) Chunyan Wang et al. Nature Communications
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
- (2021) Yafei Liu et al. CELL
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
- (2021) Emma C Wall et al. LANCET
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
- (2021) Stacey A. Lapp et al. PLoS One
- Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
- (2021) Hannah A. D. King et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
- (2021) David R. Martinez et al. SCIENCE
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
- (2021) Donal T. Skelly et al. Nature Communications
- The landscape of antibody binding in SARS-CoV-2 infection
- (2021) Anna S. Heffron et al. PLOS BIOLOGY
- Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
- (2021) Nikhil Faulkner et al. eLife
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
- (2021) Paulina Kaplonek et al. Science Immunology
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Stabilized coronavirus spike stem elicits a broadly protective antibody
- (2021) Ching-Lin Hsieh et al. Cell Reports
- A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
- (2021) Kathryn McGuckin Wuertz et al. npj Vaccines
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
- (2020) Catherine F Houlihan et al. LANCET
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- (2020) Yanqun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
- (2020) Phuong Nguyen-Contant et al. mBio
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors
- (2017) Fumiji Saito et al. NATURE
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- Re-Engaging Cross-Reactive Memory B Cells: The Influenza Puzzle
- (2012) Ali H. Ellebedy et al. Frontiers in Immunology
- The dominance of human coronavirus OC43 and NL63 infections in infants
- (2011) Ronald Dijkman et al. JOURNAL OF CLINICAL VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started